A citation-based method for searching scientific literature

Zhuo Chen, Katherine Kolor, Scott D Grosse, Juan L Rodriguez, Julie A Lynch, Ridgely Fisk Green, W David Dotson, M Scott Bowen, Muin J Khoury. Genet Med 2018
Times Cited: 29







List of co-cited articles
100 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Use of BRCA Mutation Test in the U.S., 2004-2014.
Fangjian Guo, Jacqueline M Hirth, Yu-Li Lin, Gwyn Richardson, Lyuba Levine, Abbey B Berenson, Yong-Fang Kuo. Am J Prev Med 2017
37
34

BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18-64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas - United States, 2009-2014.
Katherine Kolor, Zhuo Chen, Scott D Grosse, Juan L Rodriguez, Ridgely Fisk Green, W David Dotson, M Scott Bowen, Julie A Lynch, Muin J Khoury. MMWR Surveill Summ 2017
20
40

Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
Deborah Cragun, Anne Weidner, Courtney Lewis, Devon Bonner, Jongphil Kim, Susan T Vadaparampil, Tuya Pal. Cancer 2017
89
24


National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
141
20


NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Mary B Daly, Robert Pilarski, Michael Berry, Saundra S Buys, Meagan Farmer, Susan Friedman, Judy E Garber, Noah D Kauff, Seema Khan, Catherine Klein,[...]. J Natl Compr Canc Netw 2017
296
17

Underuse of BRCA testing in patients with breast and ovarian cancer.
Jason D Wright, Ling Chen, Ana I Tergas, Melissa Accordino, Cande V Ananth, Alfred I Neugut, Dawn L Hershman. Am J Obstet Gynecol 2016
25
20

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
867
17


Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
Joanne Armstrong, Michele Toscano, Nancy Kotchko, Sue Friedman, Marc D Schwartz, Katherine S Virgo, Kristian Lynch, James E Andrews, Claudia X Aguado Loi, Joseph E Bauer,[...]. JAMA Oncol 2015
79
17

Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data.
Julie A Lynch, Brygida Berse, W David Dotson, Muin J Khoury, Nicole Coomer, John Kautter. Genet Med 2017
23
17

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
Douglas E Levy, Stacey D Byfield, Catherine B Comstock, Judy E Garber, Sapna Syngal, William H Crown, Alexandra E Shields. Genet Med 2011
155
13


BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.
Shoshana M Rosenberg, Kathryn J Ruddy, Rulla M Tamimi, Shari Gelber, Lidia Schapira, Steven Come, Virginia F Borges, Bryce Larsen, Judy E Garber, Ann H Partridge. JAMA Oncol 2016
74
13

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
Allison W Kurian, Yun Li, Ann S Hamilton, Kevin C Ward, Sarah T Hawley, Monica Morrow, M Chandler McLeod, Reshma Jagsi, Steven J Katz. J Clin Oncol 2017
133
13

Impact of Payer Constraints on Access to Genetic Testing.
Pat Whitworth, Peter Beitsch, Christopher Arnell, Hannah C Cox, Krystal Brown, John Kidd, Johnathan M Lancaster. J Oncol Pract 2017
24
16

Impact of a genetic counseling requirement prior to genetic testing.
David D Stenehjem, Trang Au, Amy M Sainski, Hillevi Bauer, Krystal Brown, Johnathan Lancaster, Vanessa Stevens, Diana I Brixner. BMC Health Serv Res 2018
13
30

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
Mark Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine Tung, Anne Armstrong,[...]. N Engl J Med 2017
10


Payer coverage policies for multigene tests.
Kathryn A Phillips, Patricia A Deverka, Julia R Trosman, Michael P Douglas, James D Chambers, Christine B Weldon, Andrew P Dervan. Nat Biotechnol 2017
25
12


Large, Prospective Analysis of the Reasons Patients Do Not Pursue BRCA Genetic Testing Following Genetic Counseling.
Sommer Hayden, Sarah Mange, Debra Duquette, Nancie Petrucelli, Victoria M Raymond. J Genet Couns 2017
22
13

Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.
Cecelia A Bellcross, Steven Leadbetter, Sharon Hensley Alford, Lucy A Peipins. Cancer Epidemiol Biomarkers Prev 2013
40
10

Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.
Anne Marie McCarthy, Mirar Bristol, Susan M Domchek, Peter W Groeneveld, Younji Kim, U Nkiru Motanya, Judy A Shea, Katrina Armstrong. J Clin Oncol 2016
75
10

Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers.
Julia Fehniger, Feng Lin, Mary S Beattie, Galen Joseph, Celia Kaplan. J Genet Couns 2013
46
10

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
10

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
10

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
10

Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system.
Cecelia A Bellcross, Lucy A Peipins, Frances A McCarty, Juan L Rodriguez, Nikki A Hawkins, Sharon Hensley Alford, Steven Leadbetter. Genet Med 2015
25
12


Delivery Of Cascade Screening For Hereditary Conditions: A Scoping Review Of The Literature.
Megan C Roberts, W David Dotson, Christopher S DeVore, Erica M Bednar, Deborah J Bowen, Theodore G Ganiats, Ridgely Fisk Green, Georgia M Hurst, Alisdair R Philp, Charité N Ricker,[...]. Health Aff (Millwood) 2018
57
10

Disparities in genetic testing: thinking outside the BRCA box.
Michael J Hall, Olufunmilayo I Olopade. J Clin Oncol 2006
120
10

Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.
Morgan Butrick, Scott Kelly, Beth N Peshkin, George Luta, Rachel Nusbaum, Gillian W Hooker, Kristi Graves, Lisa Feeley, Claudine Isaacs, Heiddis B Valdimarsdottir,[...]. Genet Med 2015
61
10

Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers.
Eli Marie Grindedal, Cecilie Heramb, Inga Karsrud, Sarah Louise Ariansen, Lovise Mæhle, Dag Erik Undlien, Jan Norum, Ellen Schlichting. BMC Cancer 2017
31
10

Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?
Kathryn A Phillips, Patricia A Deverka, Gillian W Hooker, Michael P Douglas. Health Aff (Millwood) 2018
77
10


Methods to identify BRCA testing in claims data.
Julie Lynch, Brygida Berse. Am J Obstet Gynecol 2016
4
50

The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011-2014.
Katrina F Trivers, Juan L Rodriguez, Summer L Cox, Barbara E Crane, Debra Duquette. Healthcare (Basel) 2015
11
18

Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.
D Cragun, D Bonner, J Kim, M R Akbari, S A Narod, A Gomez-Fuego, J D Garcia, S T Vadaparampil, Tuya Pal. Breast Cancer Res Treat 2015
51
6

Growth of molecular diagnostics and genetic testing in the USA, 2008-2011: analysis and implications.
Jeanne De Sa, Brantley Carlson, Nadine Caputo, Deneen Vojta, Lewis Sandy, Simon Stevens. Per Med 2013
9
22



Population-Based Lynch Syndrome Screening by Microsatellite Instability in Patients ≤50: Prevalence, Testing Determinants, and Result Availability Prior to Colon Surgery.
Jordan J Karlitz, Mei-Chin Hsieh, Yong Liu, Christine Blanton, Beth Schmidt, J Milburn Jessup, Xiao-Cheng Wu, Vivien W Chen. Am J Gastroenterol 2015
36
6

Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative.
L Brannon Traxler, Monique L Martin, Alice S Kerber, Cecelia A Bellcross, Barbara E Crane, Victoria Green, Roland Matthews, Nancy M Paris, Sheryl G A Gabram. Ann Surg Oncol 2014
18
11

Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution.
Ian K Komenaka, Jesse N Nodora, Lisa Madlensky, Lisa M Winton, Meredith A Heberer, Richard B Schwab, Jeffrey N Weitzel, Maria Elena Martinez. J Community Genet 2016
25
8


Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
Heidi D Nelson, Miranda Pappas, Bernadette Zakher, Jennifer Priest Mitchell, Leila Okinaka-Hu, Rongwei Fu. Ann Intern Med 2014
157
6

Creation of a network to promote universal screening for Lynch syndrome: the LynchSyndrome Screening Network.
Sarah Mange, Cecelia Bellcross, Deborah Cragun, Deb Duquette, Lisa Gorman, Heather Hampel, Kory Jasperson. J Genet Couns 2015
20
10

Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2.
Michael Dean, Joseph Boland, Meredith Yeager, Kate M Im, Lisa Garland, Maria Rodriguez-Herrera, Mylen Perez, Jason Mitchell, David Roberson, Kristine Jones,[...]. Gigascience 2015
30
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.